Quantifying HIV-1-specific CD8+ T-cell responses using ELISPOT and cytokine flow cytometry

Methods in Molecular Biology

Volumn 485, Issue , 2009, Pages 359-374

  Shacklett, Barbara L ^a   Critchfield, J William ^a   Lemongello, Donna ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytokine; ELISPOT; Flow cytometry; T cell

Indexed keywords

CYTOKINE;

ARTICLE; BIOSYNTHESIS; CD8+ T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METHODOLOGY; VIROLOGY;

CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 60349086850     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-170-3_24     Document Type: Article

References (37)

1. Altman, J. D., Moss, P. A., Goulder, P. J., et al. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96.
2. Ogg, G. S., Jin, X., Bonhoeffer, S., et al. (1998) Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279, 2103-2106.
3. Coligan, J., Kruisbeek, A., Margulies, D., et al. (1999), Current Protocols in Immunology, Wiley Interscience, New York.
4. Nixon, D. F., Townsend, A. R., Elvin, J. G., et al. (1988) HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336, 484-487.
5. Doherty, P. C. (1998) The new numbers game for virus-specific CD8+ T cells. Science 280, 227.
6. Tan, L. C., Gudgeon, N., Annels, N. E., et al. (1999) A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J Immunol 162, 1827-1835.
7. Lalvani, A., Brookes, R., Hambleton, S., et al. (1997) Rapid effector function in CD8+ memory T cells. J ExpMed 186, 859-865.
8. Russell, N. D., Hudgens, M. G., Ha, R., et al. (2003) Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity. J Infect Dis 187, 226-242.
9. Anthony, D. D., Lehmann, P. V. (2003) T-cell epitope mapping using the ELISPOT approach. Methods 29, 260-269.
10. Addo, M. M., Yu, X. G., Rathod, A., et al. (2003) Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 77, 2081-2092.
11. Perfetto, S. P., Chattopadhyay, P. K., Roederer, M. (2004) Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol 4, 648-655.
12. Betts, M. R., Nason, M. C., West, S. M., et al. (2006) HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107, 4781-4789.
13. Picker, L. J., Singh, M. K., Zdraveski, Z., et al. (1995) Direct demonstration of cytokine synthesis heterogeneity among human memory/ effector T cells by flow cytometry. Blood 86, 1408-1419.
14. Komanduri, K. V., Viswanathan, M. N., Wieder, E. D., et al. (1998) Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med 4, 953-956.
15. Betts, M. R., Koup, R. A. (2004) Detection of T-Cell Degranulation: CD107a and b, in: Cytometry, New Developments, Vol. 75, pp. 497-512 (Darzynkiewicz, Z., Roederer, M. and Tanke, H. J., Eds.) Elsevier Press, San Diego, CA.
16. Kern, F., Surel, I. P., Brock, C., et al. (1998) T-cell epitope mapping by flow cytometry. Nat Med 4, 975-978.
17. Betts, M. R., Ambrozak, D. R., Douek, D. C., et al. (2001) Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4( + ) and CD8( + ) T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection. J Virol 75, 11983-11991.
18. Cherepnev, G., Volk, H. D., Kern, F. (2004) Use of Peptides and Peptide Libraries as T-Cell Stimulants in Flow Cytometric Studies, in (Darzynkiewicz, Z., Roederer, M. and Tanke, H. J., Eds.), Methods in Cell Biology, Vol. 75, pp. 453-479 Elsevier, San Diego.
19. Herr, W., Protzer, U., Lohse, A. W., et al. (1998) Quantification of CD8+ T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure. J Infect Dis 178, 260-265.
20. Janetzki, S., Schaed, S., Blachere, N. E., et al. (2004) Evaluation of Elispot assays: influence of method and operator on variability of results. J Immunol Methods 291, 175-183.
21. Larsson, M., Jin, X., Ramratnam, B., et al. (1999) A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS 13, 767-777.
22. Currier, J. R., Kuta, E. G., Turk, E., et al. (2002) A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J Immunol Methods 260, 157-172.
23. Harari, A., Rizzardi, G. P., Ellefsen, K., et al. (2002) Analysis of HIV-1- and CMVspecific memory CD4 T-cell responses during primary and chronic infection. Blood 100, 1381-1387.
24. Sandberg, J. K., Fast, N. M., Nixon, D. F. (2001) Functional heterogeneity of cytokines and cytolytic effector molecules in human cd8( + ) t lymphocytes. J Immunol 167, 181-187.
25. Betts, M. R., Brenchley, J. M., Price, D. A., et al. (2003) Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281, 65-78.
26. Roederer, M., De Rosa, S., Gerstein, R., et al. (1997) 8 color, 10-parameter flow cytometry to elucidate complex leukocyte heterogeneity. Cytometry 29, 328-339.
27. Mwau, M., McMichael, A. J., Hanke, T. (2002) Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines. AIDS Res Hum Retroviruses 18, 611-618.
28. Betts, M. R., Price, D. A., Brenchley, J. M., et al. (2004) The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration. J Immunol 172, 6407-6417.
29. CDC (1987) Recommendations for Prevention of HIV Transmission in Health-Care Settings. MMWR 36, 3S-18S.
30. Hudgens, M. G., Self, S. G., Chiu, Y. L., et al. (2004) Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials. J Immunol Methods 288, 19-34.
31. Jennes, W., Kestens, L., Nixon, D., et al. (2002) Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15-the Amplispot assay. J Immunol Methods 270, 99-108.
32. Ott, P. A., Berner, B. R., Herzog, B. A., et al. (2004) CD28 costimulation enhances the sensitivity of the ELISPOT assay for detection of antigen-specific memory effector CD4 and CD8 cell populations in human diseases. J Immunol Methods 285, 223-235.
33. Altfeld, M. A., Trocha, A., Eldridge, R. L., et al. (2000) Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay. J Virol 74, 8541-8549.
34. Larsson, M., Wilkens, D. T., Fonteneau, J. F., et al. (2002) Amplification of low-frequency antiviral CD8+ T-cell responses using autologous dendritic cells. AIDS 16, 171-180.
35. Lamoreaux, L., Roederer, M., Koup, R. (2006) Intracellular cytokine optimization and standard operating procedure. Nature Protocols 1, 1507-1516.
36. Maecker, H. T., Rinfret, A., D'Souza, P., Darden, J., Roig, E., Landry, C. et al. (2005) Standardization of cytokine flow cytometry assays. BMC Immunol 6, 13.
37. Perfetto, S. P., Chattopadhyay, P. K., Lamoreaux, L., et al. (2006) Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. J Immunol Methods 313, 199-208.